Paired Immunoglobin-like Receptor-B Regulates the Suppressive Function and Fate of Myeloid-Derived Suppressor Cells

被引:150
作者
Ma, Ge [1 ]
Pan, Ping-Ying [1 ]
Eisenstein, Samuel [2 ]
Divino, Celia M. [2 ]
Lowell, Clifford A. [6 ]
Takai, Toshiyuki [7 ]
Chen, Shu-Hsia [1 ,2 ,3 ,4 ,5 ]
机构
[1] Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA
[2] Mt Sinai Sch Med, Dept Surg, New York, NY 10029 USA
[3] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA
[4] Mt Sinai Sch Med, Inst Immunol, New York, NY 10029 USA
[5] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY 10029 USA
[6] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA
[7] Tohoku Univ, Inst Dev Aging & Canc, Dept Expt Immunol, Sendai, Miyagi 9808575, Japan
关键词
TUMOR-ASSOCIATED MACROPHAGES; MHC CLASS-I; IMMUNE SUPPRESSION; BEARING HOST; KAPPA-B; ACTIVATION; POLARIZATION; TOLERANCE; MICE; CANCER;
D O I
10.1016/j.immuni.2011.02.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Myeloid-derived suppressor cells (MDSCs) bear characteristics of precursors for both M1 and M2 macrophages. The molecular mechanism underlying the differentiation into M1 and M2 macrophages and the relationship of this differentiation to antitumor responses remains largely undefined. Herein, we investigate the potential function of paired immunoglobulin-like receptor B (PIR-B), also known as leukocyte immunoglobulin-like receptor subfamily B member 3 (LILRB3) in MDSC differentiation, and its role in tumor-induced immunity. Our studies indicated that MDSCs genetically ablated for PIR-B (Lilrb3(-/-)) underwent a specific transition to M1-like cells when entering the periphery from bone marrow, resulting in decreased suppressive function, regulatory T cell activation activity, primary tumor growth, and lung metastases. Activation of Toll-like receptor (TLR), signal transducers, and activators of transcription 1 (STAT1), and nuclear factor-kappa B (NF-kappa B) signaling in Lilrb3(-/-) MDSC promoted the acquisition of M1 phenotype. Inhibition of the PIR-B signaling pathway promoted MDSC differentiation into M1 macrophages.
引用
收藏
页码:385 / 395
页数:11
相关论文
共 45 条
[1]   Regulation of macrophage nitric oxide production by the protein tyrosine phosphatase Src homology 2 domain phosphotyrosine phosphatase 1 (SHP-1) [J].
Blanchette, Julie ;
Abu-Dayyeh, Issa ;
Hassani, Kasra ;
Whitcombe, Lorie ;
Olivier, Martin .
IMMUNOLOGY, 2009, 127 (01) :123-133
[2]   Conditional macrophage ablation in transgenic mice expressing a Fas-based suicide gene [J].
Burnett, SH ;
Kershen, EJ ;
Zhang, JY ;
Zeng, L ;
Straley, SC ;
Kaplan, AM ;
Cohen, DA .
JOURNAL OF LEUKOCYTE BIOLOGY, 2004, 75 (04) :612-623
[3]   PKC- and ERK-dependent activation of IκB kinase by lipopolysaccharide in macrophages:: enhancement by P2Y receptor-mediated CaMK activation [J].
Chen, BC ;
Lin, WW .
BRITISH JOURNAL OF PHARMACOLOGY, 2001, 134 (05) :1055-1065
[4]  
DAVID M, 1995, MOL CELL BIOL, V15, P7050
[5]   The carboxyl terminus of the granulocyte colony- stimulating factor receptor, truncated in patients with severe congenital neutropenia/acute myeloid leukemia, is required for SH2-containing phosphatase-1 suppression of Stat activation [J].
Dong, F ;
Qiu, YL ;
Yi, TL ;
Touw, IP ;
Larner, AC .
JOURNAL OF IMMUNOLOGY, 2001, 167 (11) :6447-6452
[6]   Alternative Activation of Macrophages: Mechanism and Functions [J].
Gordon, Siamon ;
Martinez, Fernando O. .
IMMUNITY, 2010, 32 (05) :593-604
[7]   Tumor versus tumor-associated macrophages: How hot is the link? [J].
Guruvayoorappan, C. .
INTEGRATIVE CANCER THERAPIES, 2008, 7 (02) :90-95
[8]   Crosstalk among Jak-STAT, toll-like receptor, and ITAM-dependent pathways in macrophage activation [J].
Hu, Xiaoyu ;
Chen, Janice ;
Wang, Lu ;
Ivashkiv, Lionel B. .
JOURNAL OF LEUKOCYTE BIOLOGY, 2007, 82 (02) :237-243
[9]   Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host [J].
Huang, B ;
Pan, PY ;
Li, QS ;
Sato, AI ;
Levy, DE ;
Bromberg, J ;
Divino, CM ;
Chen, SH .
CANCER RESEARCH, 2006, 66 (02) :1123-1131
[10]   A Novel Chemoimmunomodulating Property of Docetaxel: Suppression of Myeloid-Derived Suppressor Cells in Tumor Bearers [J].
Kodumudi, Krithika N. ;
Woan, Karrune ;
Gilvary, Danielle L. ;
Sahakian, Eva ;
Wei, Sheng ;
Djeu, Julie Y. .
CLINICAL CANCER RESEARCH, 2010, 16 (18) :4583-4594